Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel V L Wilkinson

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Angewandte Chemie (International Ed. in English)|March 14, 2022
Functionalised Cofactor Mimics for Interactome Discovery and BeyondIsabel V L Wilkinson, Martin Pfanzelt, Stephan A Sieber
Drug Discovery Today|September 24, 2020
Combining experimental strategies for successful target deconvolutionIsabel V L Wilkinson, Georg C Terstappen, Angela J Russell
Angewandte Chemie (International Ed. in English)|December 10, 2022
Profiling the Heme-Binding Proteomes of Bacteria Using Chemical ProteomicsIsabel V L Wilkinson, Max Bottlinger, Yassmine El Harraoui, et al.
Biochemical Society Transactions|June 30, 2020
From diagnosis to therapy in Duchenne muscular dystrophyArran Babbs, Maria Chatzopoulou, Ben Edwards, et al.
Bioorganic Chemistry|November 18, 2019
Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferaseIsabel V L Wilkinson, Jessica K Reynolds, Sébastien R G Galan, et al.
Chembiochem : a European Journal of Chemical Biology|December 20, 2022
The Cyanobacterial "Nutraceutical" Phycocyanobilin Inhibits Cysteine Protease LegumainIsabel V L Wilkinson, Gabriel Castro-Falcón, Maria C Roda-Serrat, et al.
Bioorganic & Medicinal Chemistry|October 31, 2020
Aminothiazolones as potent, selective and cell active inhibitors of the PIM kinase familyCamilo E Quevedo, Carole J R Bataille, Simon Byrne, et al.
Journal of Medicinal Chemistry|October 11, 2019
Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-<i>trans</i>-Dihydro-1,2-diol Metabolites of the Utrophin Modulator EzutromidMaria Chatzopoulou, Tim D W Claridge, Kay E Davies, et al.
European Journal of Medicinal Chemistry|April 29, 2021
Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophyAini Vuorinen, Isabel V L Wilkinson, Maria Chatzopoulou, et al.
Angewandte Chemie (International Ed. in English)|November 23, 2019
Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator EzutromidIsabel V L Wilkinson, Kelly J Perkins, Hannah Dugdale, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Angewandte Chemie (International Ed. in English)|March 14, 2022
Functionalised Cofactor Mimics for Interactome Discovery and BeyondIsabel V L Wilkinson, Martin Pfanzelt, Stephan A Sieber
Drug Discovery Today|September 24, 2020
Combining experimental strategies for successful target deconvolutionIsabel V L Wilkinson, Georg C Terstappen, Angela J Russell
Angewandte Chemie (International Ed. in English)|December 10, 2022
Profiling the Heme-Binding Proteomes of Bacteria Using Chemical ProteomicsIsabel V L Wilkinson, Max Bottlinger, Yassmine El Harraoui, et al.
Biochemical Society Transactions|June 30, 2020
From diagnosis to therapy in Duchenne muscular dystrophyArran Babbs, Maria Chatzopoulou, Ben Edwards, et al.
Bioorganic Chemistry|November 18, 2019
Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferaseIsabel V L Wilkinson, Jessica K Reynolds, Sébastien R G Galan, et al.
Chembiochem : a European Journal of Chemical Biology|December 20, 2022
The Cyanobacterial "Nutraceutical" Phycocyanobilin Inhibits Cysteine Protease LegumainIsabel V L Wilkinson, Gabriel Castro-Falcón, Maria C Roda-Serrat, et al.
Bioorganic & Medicinal Chemistry|October 31, 2020
Aminothiazolones as potent, selective and cell active inhibitors of the PIM kinase familyCamilo E Quevedo, Carole J R Bataille, Simon Byrne, et al.
Journal of Medicinal Chemistry|October 11, 2019
Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-<i>trans</i>-Dihydro-1,2-diol Metabolites of the Utrophin Modulator EzutromidMaria Chatzopoulou, Tim D W Claridge, Kay E Davies, et al.
European Journal of Medicinal Chemistry|April 29, 2021
Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophyAini Vuorinen, Isabel V L Wilkinson, Maria Chatzopoulou, et al.
Angewandte Chemie (International Ed. in English)|November 23, 2019
Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator EzutromidIsabel V L Wilkinson, Kelly J Perkins, Hannah Dugdale, et al.
Pageof 2